Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
Primary objective: To examine whether the switch to paliperidone ER from risperidone improves cognitive function in stabilized patients with schizophrenia. Secondary objectives: To compare the general clinical outcomes (efficacy and safety) after switching to paliperidone ER from risperidone
Epistemonikos ID: 29d2aba4009bab4fdb178f7e13b7e2385a3502a0
First added on: May 05, 2024